流行性感冒人工自动免疫同某些传染病菌苗接种一样,是促使有机体进行积极自我改造,以提高对流行性感冒病原体的适应能力。此原则早已为学者们应用到实际中去,无论在流行病学上或实验室内,都展开了大量的观察和研究工作,并已收到了一些成绩。某些研究者曾证实流行性感冒人工自动免疫同患流感病后所获得的免疫力一样可维持1—2年之久。在此时间,接种者可减少相对病毒之感染。但按现行之免疫法,免 Artificial autoimmune influenza vaccination, like vaccination of certain infectious agents, is to promote positive self-transformation of organisms in order to improve the ability to adapt to influenza pathogens. This principle has long been applied by academics to the realities. There has been a great deal of observation and research both in epidemiology and in laboratories, and some achievements have been received. Some researchers have demonstrated that AI autoimmune immunity can last as long as 1-2 years after the flu was acquired. At this time, the vaccinee can reduce the relative virus infection. But according to the current immunization law, free